Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases

By: via Benzinga
Celgene Corporation (Nasdaq: CELG) and Juno Therapeutics, Inc. (Nasdaq: JUNO) announced today a global collaboration for the development ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.